Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 369, Issue 2, pp 179–183 | Cite as

Involvement of α1 and β-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse α-cell

Original Article


Stimulation of glucagon release and inhibition of insulin secretion from the islets of Langerhans are important for the blood-glucose-elevating effect of adrenaline. The mechanisms by which adrenaline accomplishes these actions may involve direct effects and indirect ones mediated by altered release of other islet hormones. In the present study we investigated how adrenaline affects the cytoplasmic Ca2+ concentration, which controls glucagon secretion from the pancreatic α-cell. The studies were performed on isolated mouse α-cells, which were identified by immunocytochemistry.

The adrenaline effects consisted of initial mobilisation of intracellular Ca2+, accompanied by voltage-dependent influx of the ion. Part of the effect could be attributed to β-adrenoceptor activation, as it was mimicked by the rise in cAMP and inhibited by the antagonist propranolol as well as the protein kinase A inhibitor adenosine 3’,5’-cyclic monophosphorothioate Rp-isomer. α1-Adrenoceptors were also involved, since the antagonists phentolamine and prazosin completely abolished the effects of adrenaline. Experiments with clonidine and yohimbine gave little evidence of a role of α2-adrenoceptors. The results indicate that α1- and β-adrenoceptors on the α-cells mediate adrenaline-stimulated glucagon secretion. The complete inhibition of the adrenaline response after blocking α1-adrenoceptors indicates an interaction with the β-adrenergic pathway.


Glucagon secretion α1-Adrenoceptors β-Adrenoceptors Calcium 



This work was supported by grants from the Swedish Medical Research Council (12X-6240), the Swedish Foundation for Strategic Research, the Swedish Foundation for International Cooperation in Research and Higher Education, the Wenner-Gren Center Foundation, the Swedish Diabetes Association, Novo-Nordisk Foundation, Family Ernfors Foundation, the Scandinavian Physiological Society and the Swedish Society for Medical Research. Dr Vieira received a scholarship from the Amerique Latine Formation Academique (ALFA) program Islet Research European and Latin American Network (IRELAN) of the European Union.


  1. Ahren B, Lundquist I (1987) α-Adrenoceptor blockade by phentolamine inhibits β-adrenergically and cholinergically induced glucagon secretion in the mouse. Horm Metab Res 19:600–603PubMedGoogle Scholar
  2. Berts A, Gylfe E, Hellman B (1995) Ca2+ oscillations in pancreatic islet cells secreting glucagon and somatostatin. Biochem Biophys Res Commun 208:644–649CrossRefPubMedGoogle Scholar
  3. Berts A, Ball A, Gylfe E, Hellman B (1996) Suppression of Ca2+ oscillations in glucagon-producing α2-cells by insulin/glucagon and amino acids. Biochim Biophys Acta 1310:212–216CrossRefPubMedGoogle Scholar
  4. Curry DL (1970) Glucagon potentiation of insulin secretion by the perfused rat pancreas. Diabetes 19:420–428PubMedGoogle Scholar
  5. Filipponi P, Gregorio F, Ferrandina C, Nicoletti I, Mannarelli C, Pippi R, Santeusanio F (1986) Alpha-adrenergic system in the modulation of pancreatic A and B cell function in normal rats. Diabetes Res Clin Pract 2:325–336PubMedGoogle Scholar
  6. García-Sáinz JA, Vázquez-Prado J, Villalobos-Molina R (1999) α1-Adrenoceptors: subtypes, signaling, and roles in health and disease. Arch Med Res 30:449–458PubMedGoogle Scholar
  7. Göpel SO, Kanno T, Barg S, Weng XG, Gromada J, Rorsman P (2000) Regulation of glucagon secretion in mouse α-cells by KATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol (Lond) 528:509–520Google Scholar
  8. Gromada J, Bokvist K, Ding WG, Barg S, Buschard K, Renström E, Rorsman P (1997) Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol 110:217–228CrossRefPubMedGoogle Scholar
  9. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450PubMedGoogle Scholar
  10. Hermansen K, Schwartz TW (1979) Differential sensitivity to somatostatin of pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Metabolism 28:1229–1233PubMedGoogle Scholar
  11. Høy M, Bokvist K, Weng XG, Hansen J, Juhl K, Berggren PO, Buschard K, Gromada J (2001) Phentolamine inhibits exocytosis of glucagon Gi2 protein-dependent activation of calcineurine in rat pancreatic α-cells. J Biol Chem 276:924–930CrossRefPubMedGoogle Scholar
  12. Johansson H, Gylfe E, Hellman B (1989) Cyclic AMP raises cytoplasmic calcium in pancreatic α2-cells by mobilizing calcium incorporated in response to glucose. Cell Calcium 10:205–211PubMedGoogle Scholar
  13. Lernmark Å (1974) The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 10:431–438Google Scholar
  14. Liu YJ, Grapengiesser E, Gylfe E, Hellman B (1996) Crosstalk between the cAMP and inositol trisphosphate signalling pathways in pancreatic β-cells. Arch Biochem Biophys 334:295–302CrossRefPubMedGoogle Scholar
  15. Liu YJ, Vieira E, Gylfe E (2004) A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting pancreatic α-cell. Cell Calcium (in press)Google Scholar
  16. Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH (1984) Insulin within islets is a physiological glucagon release inhibitor. J Clin Invest 74:2296–2299PubMedGoogle Scholar
  17. Nakaki T, Nakadate T, Kato R (1980) α2-adrenoceptors modulating insulin release from isolated pancreatic islets. Naunyn-Schmiedebergs Arch Pharmacol 313:151–153Google Scholar
  18. Orci L (1985) The insulin factory: a tour of the plant surroundings and a visit to the assembly line. The Minkowski lecture 1973 revisited. Diabetologia 28:528–546PubMedGoogle Scholar
  19. Saito M, Saitoh T, Inoue S (1992) Alpha 2-adrenergic modulation of pancreatic glucagon secretion in rats. Physiol Behav 51:1165–1171CrossRefPubMedGoogle Scholar
  20. Schuit FC, Pipeleers DG (1986) Difference in adrenergic recognition by pancreatic A and B cells. Science 232:875–877PubMedGoogle Scholar
  21. Skoglund G, Lundquist I, Ahren B (1987) Alpha 1- and alpha 2-adrenoceptor activation increases plasma glucagon levels in the mouse. Eur J Pharmacol 143:83–88CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Department of Medical Cell BiologyUppsala University BiomedicumUppsalaSweden

Personalised recommendations